Kimmo Palin
Kimmo Palin
Cancer Researcher, Research Program in Cancer Research, Univeristy of Helsinki
Verified email at - Homepage
Cited by
Cited by
DNA-binding specificities of human transcription factors
A Jolma, J Yan, T Whitington, J Toivonen, KR Nitta, P Rastas, ...
Cell 152 (1-2), 327-339, 2013
Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls
Wellcome Trust Case Control Consortium
Nature 464 (7289), 713, 2010
Genome‐wide analysis of ETS‐family DNA‐binding in vitro and in vivo
GH Wei, G Badis, MF Berger, T Kivioja, K Palin, M Enge, M Bonke, ...
The EMBO journal 29 (13), 2147-2160, 2010
Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity
O Hallikas, K Palin, N Sinjushina, R Rautiainen, J Partanen, E Ukkonen, ...
Cell 124 (1), 47-59, 2006
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
S Tuupanen, M Turunen, R Lehtonen, O Hallikas, S Vanharanta, T Kivioja, ...
Nature genetics 41 (8), 885-890, 2009
Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities
A Jolma, T Kivioja, J Toivonen, L Cheng, G Wei, M Enge, M Taipale, ...
Genome research 20 (6), 861-873, 2010
Bayesian refinement of association signals for 14 loci in 3 common diseases
JB Maller, G McVean, J Byrnes, D Vukcevic, K Palin, Z Su, JMM Howson, ...
Nature genetics 44 (12), 1294-1301, 2012
CTCF/cohesin-binding sites are frequently mutated in cancer
R Katainen, K Dave, E Pitkänen, K Palin, T Kivioja, N Välimäki, AE Gylfe, ...
Nature genetics 47 (7), 818-821, 2015
From gene networks to gene function
T Schlitt, K Palin, J Rung, S Dietmann, M Lappe, E Ukkonen, A Brazma
Genome research 13 (12), 2568-2576, 2003
Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity
M Turunen, JM Spaeth, S Keskitalo, MJ Park, T Kivioja, AD Clark, ...
Cell reports 7 (3), 654-660, 2014
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ...
Nature communications 10 (1), 1-15, 2019
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis
S May-Wilson, A Sud, PJ Law, K Palin, S Tuupanen, A Gylfe, ...
European Journal of Cancer 84, 228-238, 2017
Identification of candidate oncogenes in human colorectal cancers with microsatellite instability
AE Gylfe, J Kondelin, M Turunen, H Ristolainen, R Katainen, E Pitkänen, ...
Gastroenterology 145 (3), 540-543. e22, 2013
Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer
H Rodriguez‐Broadbent, PJ Law, A Sud, K Palin, S Tuupanen, A Gylfe, ...
International journal of cancer 140 (12), 2701-2708, 2017
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
D Jarvis, JS Mitchell, PJ Law, K Palin, S Tuupanen, A Gylfe, UA Hänninen, ...
British journal of cancer 115 (2), 266-272, 2016
Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer
E Pitkänen, T Cajuso, R Katainen, E Kaasinen, N Välimäki, K Palin, ...
Oncotarget 5 (3), 853, 2014
Locating potential enhancer elements by comparative genomics using the EEL software
K Palin, J Taipale, E Ukkonen
Nature protocols 1 (1), 368-374, 2006
Identity‐by‐descent‐based phasing and imputation in founder populations using graphical models
K Palin, H Campbell, AF Wright, JF Wilson, R Durbin
Genetic epidemiology 35 (8), 853-860, 2011
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
UA Hänninen, R Katainen, T Tanskanen, RM Plaketti, R Laine, ...
PLoS genetics 14 (3), e1007200, 2018
Multiple clinical characteristics separate MED12-mutation-positive and-negative uterine leiomyomas
HR Heinonen, A Pasanen, O Heikinheimo, T Tanskanen, K Palin, ...
Scientific reports 7 (1), 1-7, 2017
The system can't perform the operation now. Try again later.
Articles 1–20